Article info
Clinical guidelines
Short report
Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility
- Correspondence to Dr Amanda B Spurdle, Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; amanda.spurdle{at}qimrberghofer.edu.au
Citation
Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility
Publication history
- Received April 23, 2020
- Revised September 8, 2020
- Accepted September 12, 2020
- First published November 9, 2020.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.